THE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIA

Background: COVID-19 is caused by the 2019 novel coronavirus (2019nCoV) which was identified on 7 January 2020 by the Chinese Center for Disease Control and Prevention (CDC) from the throat swab sample of a patient. This novel coronavirus is phylogenetically similar to the severe acute respiratory s...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ade Dilaruri, Ira Rahmawati
Formato:	article
Lenguaje:	EN
Publicado:	Belitung Raya Foundation 2020
Materias:	covid-19 chloroquine oseltamivir coronavirus psychosocial support indonesia Nursing RT1-120
Acceso en línea:	https://doi.org/10.33546/bnj.1132 https://doaj.org/article/d32b1c8c879a44f894b385d536fe8486
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d32b1c8c879a44f894b385d536fe8486
record_format	dspace
spelling	oai:doaj.org-article:d32b1c8c879a44f894b385d536fe84862021-12-02T12:34:31ZTHE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIAhttps://doi.org/10.33546/bnj.11322477-40732477-4073https://doaj.org/article/d32b1c8c879a44f894b385d536fe84862020-06-01T00:00:00Zhttps://belitungraya.org/BRP/index.php/bnj/article/view/1132https://doaj.org/toc/2477-4073https://doaj.org/toc/2477-4073Background: COVID-19 is caused by the 2019 novel coronavirus (2019nCoV) which was identified on 7 January 2020 by the Chinese Center for Disease Control and Prevention (CDC) from the throat swab sample of a patient. This novel coronavirus is phylogenetically similar to the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused SARS outbreak in 2002. Objective: To describe a case of a COVID -19 patient in a hospital in Indonesia. Case Report: A 55-year-old male was admitted to the Emergency Department of Arifin Achmad Hospital on 31 March 2020. He was transferred from a private hospital after three days of hospitalization. Previously, he came to another hospital complaining palpitation, cough, having difficulty of breathing, and intermittent fever. He then was advised to be admitted and tested for a COVID-19 test. At first, he did not admit to having traveled recently. After three days, the pharyngeal swab test was received confirming that he was contracted with COVID-19. The patient was then transferred to our hospital and hospitalized for ten days. Discussion: The patient was fully recovered after ten days of treatment with antiviral drug namely Oseltamivir 75 mg orally twice a day and chloroquine phosphate 500 mg twice a day orally. The combination of both drugs showed an immune-modulating activity which might increase its antiviral effects. Therefore, the use of this agent in COVID-19 patients might be worthwhile. During hospitalization, reducing patient anxiety was also one of our main goals as many studies has found that anxiety is associated with poor immune system. Conclusion: This case report demonstrated the current situation in Indonesia where people become reluctant to fully disclose their symptoms or travel history to the health care workers, which may put many others on the risk of being transmitted with the virus. Although the proven efficacy of chloroquine is still lacking, it has become the favorable choice at this moment as indicated in our study. Reducing the patient’s anxiety towards the disease may help to speed the patient’s recovery. Also, we need to educate public that COVID-19 might be a life-threatening disease but it is also a treatable disease.Ade DilaruriIra RahmawatiBelitung Raya Foundationarticlecovid-19chloroquineoseltamivircoronaviruspsychosocial supportindonesiaNursingRT1-120ENBelitung Nursing Journal, Vol 6, Iss 3, Pp 97-102 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	covid-19 chloroquine oseltamivir coronavirus psychosocial support indonesia Nursing RT1-120
spellingShingle	covid-19 chloroquine oseltamivir coronavirus psychosocial support indonesia Nursing RT1-120 Ade Dilaruri Ira Rahmawati THE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIA
description	Background: COVID-19 is caused by the 2019 novel coronavirus (2019nCoV) which was identified on 7 January 2020 by the Chinese Center for Disease Control and Prevention (CDC) from the throat swab sample of a patient. This novel coronavirus is phylogenetically similar to the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused SARS outbreak in 2002. Objective: To describe a case of a COVID -19 patient in a hospital in Indonesia. Case Report: A 55-year-old male was admitted to the Emergency Department of Arifin Achmad Hospital on 31 March 2020. He was transferred from a private hospital after three days of hospitalization. Previously, he came to another hospital complaining palpitation, cough, having difficulty of breathing, and intermittent fever. He then was advised to be admitted and tested for a COVID-19 test. At first, he did not admit to having traveled recently. After three days, the pharyngeal swab test was received confirming that he was contracted with COVID-19. The patient was then transferred to our hospital and hospitalized for ten days. Discussion: The patient was fully recovered after ten days of treatment with antiviral drug namely Oseltamivir 75 mg orally twice a day and chloroquine phosphate 500 mg twice a day orally. The combination of both drugs showed an immune-modulating activity which might increase its antiviral effects. Therefore, the use of this agent in COVID-19 patients might be worthwhile. During hospitalization, reducing patient anxiety was also one of our main goals as many studies has found that anxiety is associated with poor immune system. Conclusion: This case report demonstrated the current situation in Indonesia where people become reluctant to fully disclose their symptoms or travel history to the health care workers, which may put many others on the risk of being transmitted with the virus. Although the proven efficacy of chloroquine is still lacking, it has become the favorable choice at this moment as indicated in our study. Reducing the patient’s anxiety towards the disease may help to speed the patient’s recovery. Also, we need to educate public that COVID-19 might be a life-threatening disease but it is also a treatable disease.
format	article
author	Ade Dilaruri Ira Rahmawati
author_facet	Ade Dilaruri Ira Rahmawati
author_sort	Ade Dilaruri
title	THE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIA
title_short	THE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIA
title_full	THE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIA
title_fullStr	THE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIA
title_full_unstemmed	THE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIA
title_sort	role of chloroquine and psychosocial support in a patient with covid-19: a case report in indonesia
publisher	Belitung Raya Foundation
publishDate	2020
url	https://doi.org/10.33546/bnj.1132 https://doaj.org/article/d32b1c8c879a44f894b385d536fe8486
work_keys_str_mv	AT adedilaruri theroleofchloroquineandpsychosocialsupportinapatientwithcovid19acasereportinindonesia AT irarahmawati theroleofchloroquineandpsychosocialsupportinapatientwithcovid19acasereportinindonesia AT adedilaruri roleofchloroquineandpsychosocialsupportinapatientwithcovid19acasereportinindonesia AT irarahmawati roleofchloroquineandpsychosocialsupportinapatientwithcovid19acasereportinindonesia
_version_	1718393829536563200

THE ROLE OF CHLOROQUINE AND PSYCHOSOCIAL SUPPORT IN A PATIENT WITH COVID-19: A CASE REPORT IN INDONESIA

Ejemplares similares